$0.2710
-0.0586-17.78%
Last update: Nov 6, 6:55 PM
Evogene Ltd (EVGN) Stock Price, Quote, News & History
EVGNNASDAQ
Evogene's stock surged on news of ICL's acquisition of Lavie Bio's operations, strengthening ICL's position in ag-biologicals.
You can purchase shares of Evogene (NASDAQ:EVGN) through any online brokerage.
Other companies in Evogene’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Evogene has a consensus price target of $3.50.
The stock price for Evogene (NASDAQ: EVGN) is $0.2501 last updated November 6, 2026 at 6:55 PM EST.
There are no upcoming dividends for Evogene.
Evogene does not have any upcoming earnings scheduled.
There is no upcoming split for Evogene.
Evogene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the...
